UK markets closed

BIOLASE, Inc. (BIOL)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1768+0.0317 (+21.85%)
At close: 04:00PM EDT
0.1652 -0.01 (-6.56%)
After hours: 05:08PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
6,566
4,181
29,972
17,564
Total cash
6,566
4,181
29,972
17,564
Net receivables
5,483
5,841
4,238
3,059
Inventory
11,433
15,884
12,929
11,157
Other current assets
555
1,166
754
573
Total current assets
24,863
28,959
49,354
35,110
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
18,374
14,584
10,833
10,422
Accumulated depreciation
-11,330
-8,538
-8,049
-7,664
Net property, plant and equipment
7,044
6,046
2,784
2,758
Goodwill
2,926
2,926
2,926
2,926
Other long-term assets
268
255
220
231
Total non-current assets
10,238
9,227
5,930
5,915
Total assets
35,101
38,186
55,284
41,025
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
2,265
700
-
-
Accounts payable
6,065
5,786
3,309
2,651
Accrued liabilities
6,178
8,140
7,313
6,197
Deferred revenues
2,452
2,111
2,259
1,905
Other current liabilities
1,363
-
-
-
Total current liabilities
19,663
17,807
13,844
11,223
Non-current liabilities
Long-term debt
11,782
13,091
13,603
16,186
Deferred revenues
256
418
329
374
Other long-term liabilities
79
362
330
1,056
Total non-current liabilities
13,482
15,490
16,232
19,774
Total liabilities
33,145
33,297
30,076
30,997
Stockholders' equity
Common stock
2,206
0
40
216
Retained earnings
-316,800
-296,168
-267,534
-251,376
Accumulated other comprehensive income
-553
-733
-623
-385
Total stockholders' equity
1,956
4,889
25,208
10,028
Total liabilities and stockholders' equity
35,101
38,186
55,284
41,025